Genvax Technologies Receives Series Seed Plus Funding to Revolutionize Vaccine Development for Animal Health Genvax Technologies, a pioneering startup in the field of RNA vaccine development for animal health, has…
Dxcover Secures $6.2 Million in Funding to Drive Growth and Expand Cancer Diagnostics Reach Dxcover Limited, a pioneering clinical-stage diagnostics company known for its cutting-edge multiomic spectral analysis technology (MOSA-Dx™)…
AliveDx has announced the receipt of IVDR-CE mark for its MosaiQ AiPlex® CTDplus multiplex assay, a significant advancement in the diagnosis and management of Systemic Autoimmune Rheumatic Diseases (SARDs). This…
Cigna Group Reports Strong 2024 Financial Results, Sets 2025 Outlook, and Announces Dividend Increase Global health company The Cigna Group (NYSE: CI) has released its financial results for the fourth…
Takeda (TOKYO:4502/NYSE:TAK) has announced its third-quarter earnings results for fiscal year 2024, reporting significant progress in its Growth & Launch Products. These products experienced robust growth, posting a 14.6% increase…
Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive…
Collaboration Announced Between Simulations Plus and ETC for GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), a leader in biosimulation and performance solutions for the biopharma industry, has entered into an exciting…
Congress 2025: United Therapeutics to Present Clinical Data at PVRI Annual Event United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that it will present five posters showcasing…
Appoints Mark R. Bamforth as CEO to Drive Growth at Kincell Bio Kincell Bio, a leader in the cell therapy development and manufacturing sector, appoints Mark R. Bamforth as Chief…
Announces Milestone KarXT NDA Acceptance for Schizophrenia, Zai Lab Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announces that China’s National Medical Products Administration (NMPA) has accepted the New Drug…
FDA Approves FoundationOne®CDx for OJEMDA™ in Pediatric Brain Tumor Foundation Medicine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved FoundationOne®CDx as a companion diagnostic for…
Agreement Between Neuraly and Enigma Biomedical USA on PET Imaging Biomarker PMI04 On January 16, 2025, Neuraly Inc., a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA,…